Immune-related findings on a scan — that are not cancer

The common ones are thyroiditis, colitis, pneumonitis, hypophysitis, hepatitis and sarcoid-like lymph nodes. Each is inflammation caused by immunotherapy switching your immune system up, not cancer. On a report they appear as thickened bowel wall, ground-glass lung shadows, an enlarged thyroid, or new symmetrical lymph nodes in the chest.

This page explains the terminology in general. It does not, and cannot, interpret your own scan report. Whether a specific finding on a specific report is immune inflammation or cancer is a judgement your treating oncologist makes using your imaging, your blood tests and your symptoms together. Nothing here is a substitute for that conversation.

The rest of this page sets out what the words on a report usually mean, how radiologists and oncologists tell inflammation apart from spread, and which findings actually lead to a change in treatment.

Timing ranges are general patterns described in NCCN, ASCO and ESMO immune-related adverse event guidance. They describe groups of patients, not your case. Response-assessment PET-CT referenced here is coordinated at partner imaging centres.

• Symmetry — immune inflammation often affects both lungs, or both sides of the chest, in a mirrored pattern that spread rarely produces.
• The organ involved — a new finding in an organ your cancer had never involved shifts the reading towards an immune reaction.
• Timing from the first dose — your team reads the date of your first cycle against the date of the scan, because most immune findings cluster in the first six months.
• Blood tests read alongside — thyroid function, liver enzymes, cortisol and inflammatory markers often move before, or with, the imaging change.
• How you actually feel — a cough, breathlessness, loose motions or new fatigue can change the reading of the very same image.
• A follow-up scan, occasionally a biopsy — where imaging alone cannot settle it, repeating the scan or sampling the area is the definitive step.

Grade bands follow the CTCAE framework referenced in NCCN and ASCO immune-related adverse event guidance. Grading is done by your treating team from your full clinical picture, never from a report on its own, and never from this page. Thyroid findings are the common exception — an underactive thyroid is usually managed with hormone replacement rather than steroids, and immunotherapy is often continued.

1. 1

   Read the impression, not only the findings list

   The findings section describes every shadow the radiologist can see. The impression is where they say what they think it means, and it often already raises the possibility of an immune reaction.

2. 2

   Write down what you have felt, and when it started

   Cough, breathlessness, loose motions, joint pain, unusual tiredness, dates. Your symptom timeline is what turns an ambiguous image into a readable one for your oncologist.

3. 3

   Ask the question directly

   “Could this finding be an immune reaction rather than cancer, and how will we tell?” It is a fair question, it is asked routinely, and it deserves a plain answer.

4. 4

   Do not stop or delay a cycle on your own

   Holding treatment is sometimes the right call, and sometimes exactly the wrong one. It is a decision for your treating team, made with the bloods and the images in front of them.

5. 5

   Keep the images, not just the printed report

   Response-assessment PET-CT is coordinated at partner imaging centres, so carry the CD or the film. A comparison against the prior scan is usually what resolves the question.

• Why Two Radiologists Read the Same Scan Differently — if two reports on the same images disagree, this explains why that happens and what your team does with it.
• Pseudoprogression: When the Tumour Looks Bigger but Treatment Is Working — the other scan pattern that reads as bad news and often is not.
• When Is the First Scan on Immunotherapy, and Why the Wait? — useful if this is your first response scan and the timing has been worrying you.
• Immunotherapy at CION Cancer Clinics — how immunotherapy is given as day care, and how monitoring and response assessment are organised around it.

This page explains general imaging and immune-reaction terminology for patient education. It does not interpret any individual scan report, and it is not a diagnosis. Timing ranges and grade bands are drawn from published guideline material from NCCN, ASCO and ESMO and describe groups of patients, not your results. Response-assessment PET-CT referenced on this page is coordinated at partner imaging centres.

Most people read their own report before anyone explains it

Wanting to understand the words on your scan is not overreacting. Our team walks through what your specific report says, in plain language, with your treatment history in front of them.